TLDR ZEC remains below a multi-year descending trendline, keeping the long-term outlook bearish. Loss of the $430 support level exposes price to deeper downsideTLDR ZEC remains below a multi-year descending trendline, keeping the long-term outlook bearish. Loss of the $430 support level exposes price to deeper downside

Zcash Price Prediction: ZEC Risks Deeper Decline as Bearish Patterns Persist

2025/12/24 08:53
3 min read

TLDR

  • ZEC remains below a multi-year descending trendline, keeping the long-term outlook bearish.
  • Loss of the $430 support level exposes price to deeper downside toward $300–$200.
  • A confirmed head-and-shoulders pattern projects potential targets near $80–$100.
  • Oversold signals may trigger bounces, but rebounds are likely corrective without trend invalidation.

Zcash (ZEC) remains under sustained pressure as multiple long-term technical structures continue to favor sellers. Analysts tracking higher timeframes highlight weakening momentum, failed recovery attempts, and limited demand below key resistance zones. Current projections suggest Zcash price could face further downside before any meaningful recovery develops.

Zcash Price Holds Above Multi-Year Downtrend

According to analyst Cryptollica, the weekly chart displays a persistent descending trendline extending from the 2018 peak near $890 to the 2021 high around $370. Price currently trades close to $414, firmly above this long-term resistance. Each rebound across cycles has produced lower highs, reinforcing the bearish structure.

SOURCE: X

Moreover, trading volume has remained subdued during recent declines, signaling limited speculative interest. This lack of participation suggests buyers are reluctant to step in aggressively. Privacy-focused assets like ZEC have historically lagged broader market recoveries before reacting sharply to specific catalysts.

Reclaiming the trendline ATH would be required to alter the outlook. Analysts noted that a confirmed break could open room toward $800 and above. Until then, downside risk remains dominant, with potential dips toward $300 or lower if support weakens.

Failed Breakout Leaves ZEC Exposed to Lower Levels

Meanwhile, Ardi’s long-term ZEC against USD analysis highlights a sharp reversal following the 2025 rally above $700. After peaking, price action shifted into a falling channel marked by lower highs and accelerating sell-offs. The recent loss of the $430 support level has reinforced bearish control.

SOURCE: X

Additionally, ZEC now trades near a critical support band between $300 and $350 on higher timeframes. Fibonacci retracement levels identify this region as a possible pause zone. However, rising volume on down candles suggests distribution rather than accumulation.

If buyers fail to defend this zone, selling pressure could intensify rapidly. Analysts warn that a breakdown would expose targets near $200. Conversely, holding this band could allow a corrective rebound toward $500, though conviction remains weak.

Head-and-Shoulders Pattern Signals Extended Weakness

Furthermore, analyst TheSolstice points to a clear head-and-shoulders formation on the weekly ZEC chart. The pattern formed after the 2025 peak, with shoulders near $500 and the head close to $700. A decisive neckline break near $400 has already played out.

The projected move from this structure targets the $80–$100 range. RSI readings have dropped below 30, reflecting oversold conditions, while funding metrics show persistent pessimism. Price also remains below key moving averages, confirming trend weakness.

SOURCE: X

In addition, liquidity appears thin below $300, increasing the risk of sharp moves during sell-offs. While oversold conditions may allow technical bounces, analysts caution that rebounds could be corrective. A recovery toward $600 would require extreme capitulation or external catalysts.

Overall, market structure continues to favor caution as bearish patterns dominate higher timeframes. The Zcash price remains trapped below major resistance zones, with sellers controlling momentum. Until trend invalidation occurs, downside risks appear elevated across multiple technical models.

The post Zcash Price Prediction: ZEC Risks Deeper Decline as Bearish Patterns Persist appeared first on CoinCentral.

Market Opportunity
Zcash Logo
Zcash Price(ZEC)
$242.15
$242.15$242.15
+2.12%
USD
Zcash (ZEC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26